Stay updated on Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays a recruitment-closed notice ('No longer looking for participants') and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study). It also includes a minor formatting change to the Intervention/Treatment label and an updated Revision tag to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T05:24:55.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, indicating a minor site update rather than a change to the study data on the page.
    Difference
    0.1%
    Check dated 2026-06-06T23:37:17.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous revision label. This reflects a minor update to the document without altering its content.
    Difference
    0.1%
    Check dated 2026-05-16T09:25:38.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-25T06:02:54.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:28:46.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Site revision updated from version v3.4.3 to v3.5.0. No visible changes to the study details or page content.
    Difference
    0.1%
    Check dated 2026-03-20T04:57:02.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent IDH-Mutated Gliomas Clinical Trial page.